Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NeoProbe gains another US patent for radio-immunoguided surgery (RIGS)

This article was originally published in Clinica

Executive Summary

NeoProbe has been awarded a US patent for "biostaging" of cancer patients using its radio-immunoguided surgery (RIGS) technology. RIGS involves injecting the patient with an agent targeted at cancer antigens and receptors and using this marker to locate small amounts of cancerous tissue. According to NeoProbe, the new patent covers the location of additional tissue not found by any other way. This can improve determination of the stage of a patient's cancer. The patent is the third granted for the RIGS technology this year.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT092006

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel